Clinical Trial Results TV
Trial / Study: 1191 submissions (showing 736 to 750)

| Page 1 | Page 2 | Page 3 | Page 4 | Page 5 | Page 6 | Page 7 | Page 8 | Page 9 | Page 10 | Page 11 | Page 12 | Page 13 | Page 14 | Page 15 | Page 16 | Page 17 | Page 18 | Page 19 | Page 20 | Page 21 | Page 22 | Page 23 | Page 24 | Page 25 | Page 26 | Page 27 | Page 28 | Page 29 | Page 30 | Page 31 | Page 32 | Page 33 | Page 34 | Page 35 | Page 36 | Page 37 | Page 38 | Page 39 | Page 40 | Page 41 | Page 42 | Page 43 | Page 44 | Page 45 | Page 46 | Page 47 | Page 48 | Page 49 | Page 50 | Page 51 | Page 52 | Page 53 | Page 54 | Page 55 | Page 56 | Page 57 | Page 58 | Page 59 | Page 60 | Page 61 | Page 62 | Page 63 | Page 64 | Page 65 | Page 66 | Page 67 | Page 68 | Page 69 | Page 70 | Page 71 | Page 72 | Page 73 | Page 74 | Page 75 | Page 76 | Page 77 | Page 78 | Page 79 | Page 80 |

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Harvey White presents: ACC Wrap-Up from a Pacific Rim Perspective, March 10, 2013
Dr. Harvey White

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Alice K. Jacobs and Dr. C. Michael Gibson discuss: A Randomized Trial to Compare Percutaneous Coronary Intervention
Dr. Alice Jacobs

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Mihai Gheorghiade and Dr. C. Michael Gibson discuss: The ASTRONAUT Study: Aliskiren Trial On Acute Heart Failure Out
Dr. Mihai Gheorghiade

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Masahiro Natsuaki and Dr. Matthew Cavender discuss: One-Year Outcome of a Trial Comparing Second Generation Drug-Elu
Dr. Masahiro Natsuaki, Dr. Matthew Cavender

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Margaret Redfield and Dr. Matthew Cavender discuss: Phosphodiesterase-5 Inhibition to Improve Clinical Status and Ex
Dr. Margaret Redfield

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Jane Margaret Armitage and Dr. C. Michael Gibson discuss: HPS2-THRIVE: Randomized Comparison Of Extended-Release (ER
Dr. Jane Armitage

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Anna Toso and Dr. Christopher U. Meduri discuss: Early High-Dose Rosuvastatin for Contrast-Induced Nephropathy Preve
Dr. Anna Toso, Dr. Chris Meduri

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Shinya Goto and Dr. C. Michael Gibson discuss: Once-Daily Esomeprazole 20 mg Prevents Recurrence of Peptic Ulcer in
Dr. Shinya Goto

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Lars Wallentin presents: AHA Wrap-Up from a Scandinavian Perspective, November 5, 2012.
Dr. Lars Wallentin

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Paul Armstrong, Dr. Jonathan Howlett, Dr. Robert Welsh and Dr. Shaun Goodman discuss: AHA Wrap-Up from a Canadian Pe
Dr. Paul W. Armstrong, Dr. Robert Welsh, Dr. Jonathan Howlett, Dr. Shaun Goodman

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Thomas R. Porter and Dr. C. Michael Gibson discuss: Prospective Evaluation of Outcomes With Stress Perfusion Imaging
Dr. Thomas Porter

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Frederick J. Raal and Dr. C. Michael Gibson discuss: Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Famili
Dr. Frederick Raal

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Gregory G. Schwartz and Dr. C. Michael Gibson discuss: Effects of the Cholesteryl Ester Transfer Protein Inhibitor D
Dr. Gregory Schwartz

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Hisao Ogawa presents: AHA Wrap-Up in Japanese, November 6, 2012
Dr. Hisao Ogawa

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Christoph Varenhorst presents: AHA Wrap-Up in Swedish, November 6, 2012
Dr. Christoph Varenhorst